About Us
The King's Thrombosis Centre is a leading multidisciplinary clinical and research group dedicated to the diagnosis and treatment of hypercoagulable conditions.
We are a designated Haemophilia Centre and were the first National Venous Thromboembolism (VTE) Exemplar Centre, reflecting our national leadership in the prevention and treatment of VTE. Our clinical trials unit works in partnership with industry to develop new treatments for VTE prevention and treatment.
What we do
Patient information
King's Thrombosis Centre are proud to have been the primary exemplar centre within the VTE Network.
Research
We are an experienced multi-disciplinary clinical academic team, conducting translational research in the field of thrombosis and haemostasis.
News
The records below have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at: http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services
Study (n=9492 with anticoagulation-associated intracerebral haemorrhage & documented reversal intervention status) found early anticoagulation reversal improved survival (door-to-treatment time ≤60min reduced inpatient mortality [adjusted odds ratio 0.83, 95% CI 0.69-1.00]).
The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at: http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services
JAMA Neurology
Delighted to have contributed to #VTE section of the new International Menopause Society recommendations. @IntlMenopause @hamoda_h25 @thrombosisday @ThrombosisUK @isth @ClimactericIMS @RCObsGyn @ThrombosisCan @AnticoagForum
Research
COMING SOON…
MHRA is asking anyone with excessive bleeding due to DOAC to report it to Yellow Card scheme, after which they may be contacted for consent to provide further information & submit a blood sample to explore if they are at higher risk of excessive bleeding due to genetic makeup.
Medicines and Healthcare products Regulatory Agency
Evidence for the interaction between SSRIs and low-dose ASA was found to be weak. It is uncertain whether adding an SSRI to low-dose ASA increases the bleeding risk. Adding low-dose ASA to an SSRI may confer an increased bleeding risk but this is also uncertain.
British Journal of Clinical Pharmacology
Delighted to have contributed to #VTE section of the new International Menopause Society recommendations. https://t.co/Cg8j17GGUv @IntlMenopause @hamoda_h25 @thrombosisday @ThrombosisUK @isth @ClimactericIMS @RCObsGyn @ThrombosisCan @AnticoagForum
Read MoreRT @RZarychanski: @BrettLHouston presenting the results of the TRACTION trial as a late-breaking at #ASH25. In 8300 pts undergoing major…
Read MoreRT @VincentRK: They did an 8000 patient clinical trial at a cost of just $1.3 million by incorporating the trial into routine clinical prac…
Read MoreRT @JeremyFarrar: Pioneering new treatment reverses incurable blood cancer in some patients https://t.co/KwG6Alw7tH
Read MoreRT @NEJM: Presented at #ASH25: In relapsed or refractory T-cell acute lymphoblastic leukemia, off-the-shelf allogeneic base-edited CAR7 T…
Read MoreRT @eugenefanbw: Our @TheLancetHaem Viewpoint calls for a multidisciplinary approach to embed sustainability into anticoagulation—aligning…
Read MoreObservational & lab data show #transdermal #HRT doesn’t increase thrombotic risk. Our study provides reassurance that transdermal #estradiol may be safely used in women with a history of thrombosis. @BrMenopauseSoc @hamoda_h25 @RCObsGyn @isth @ThrombosisUK https://t.co/pvHMYQoKJN
Read More@barneyronay Wonderful writing, thank you!
Read MoreRT @MaryCushmanMD: Is this the end of rivaroxaban for acute VTE? @LanaCastellucci presenting the COBBRA trial - 1st RCT comparing apixaban…
Read MoreWonderful to participate in first #Space #Haematology session at a Haematology conference thanks to #EHA2025 ! Pleasure to share the stage with @joseph_borg_ & Judith-Irina Buchheim covering rbc, wbc and clotting changes in space. @EHA_Hematology @BritSocHaem @ASH_hematology https://t.co/yo4sZ241B2
Read More